chevron_leftBack
V
As of 8 July 2026, Virax Biolabs Group Ltd. Class A has a market cap of $2.42M USD, ranking #46948 globally and #1079 in the United Kingdom.
It ranks #4685 in the Financial Services sector, and #891 in the Financial Conglomerates industry.
Key Stats
Market Cap
$2.42MUSD
Company Profile
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -2.3% | -5.3% | -39% | -24% | -70% | -86% |
News
Loading...
VRAX Analyst Forecasts
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
VRAX
ISIN: KYG9495L1335
Shares Out.:
Shares Outstanding:
796.988K1
Shares Float:
782.696K2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
3.04 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
LSE: MNG
|
$9.53B
393K%
7.13B GBP
|
24.3
|
|
LSE: ZEG
|
$5.15B
212K%
3.85B GBP
|
-
|
|
LSE: CGEO
|
$1.58B
65K%
1.18B GBP
|
2.7
|
|
NASDAQ: DSAC
|
$338.82M
14K%
|
381.1
|
|
NASDAQ: AXIN
|
$277.57M
11K%
|
69.6
|
|
LSE: ARBB
|
$185.79M
8K%
139.02M GBP
|
7.8
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
STO: INVE-A
|
$117.53B
5M%
1.14T SEK
|
5.9
|
|
KRX: 402340
|
$72.35B
3M%
109.46T KRW
|
12.5
|
|
BVMF: ITSA3
|
$30.39B
1M%
157.1B BRL
|
9.5
|
|
STO: INDU-A
|
$21.48B
887K%
207.94B SEK
|
5.2
|
|
TWSE: 2887
|
$18.61B
768K%
598.03B TWD
|
12.6
|
|
AMS: HAL
|
$17.58B
726K%
15.4B EUR
|
9.6
|
chevron_leftBack